MediWound (MDWD) – Hot Corp. News
-
MediWound (MDWD) Phase 3 Pediatric Study (CIDS) of NexoBrid for Eschar Removal of Severe Thermal Burns Mets Primary Endpoints
-
MediWound (MDWD) Receives CRL from U.S. FDA for NexoBrid Biologics License
-
-
-
-
Back to MDWD Stock Lookup